ici 204,219 has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Medany, AA; El-Sabah, DM; Hager, HH; Mahgoub, AA; Mustafa, AA | 1 |
| Sun, A; Xu, X; Yan, L | 1 |
2 other study(ies) available for ici 204,219 and malondialdehyde
| Article | Year |
|---|---|
Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon.
Topics: Acetic Acid; Animals; Catalase; Colitis; Colon; Coloring Agents; Glutathione; Indoles; Leukotriene Antagonists; Male; Malondialdehyde; Peroxidase; Phenylcarbamates; Rats; Rats, Wistar; Sulfonamides; Tosyl Compounds | 2003 |
Zafirlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces the Effect of Advanced Glycation End-Products in Rat Renal Mesangial Cells In Vitro.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione Peroxidase; Glycation End Products, Advanced; Indoles; Inflammation; Malondialdehyde; Mesangial Cells; Oxidative Stress; Phenylcarbamates; Rats; Reactive Oxygen Species; Receptors, Leukotriene; Sulfonamides; Superoxide Dismutase; Tosyl Compounds; Tumor Necrosis Factor-alpha | 2019 |